265 related articles for article (PubMed ID: 12047461)
1. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
Diener HC; Matias-Guiu J; Hartung E; Pfaffenrath V; Ludin HP; Nappi G; De Beukelaar F
Cephalalgia; 2002 Apr; 22(3):209-21. PubMed ID: 12047461
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
Gawel MJ; Kreeft J; Nelson RF; Simard D; Arnott WS
Can J Neurol Sci; 1992 Aug; 19(3):340-5. PubMed ID: 1393843
[TBL] [Abstract][Full Text] [Related]
3. Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial.
Cao K; Han F; Lin A; Yang W; Zhao J; Zhang H; Ding Y; Xie W; Xu Y; Yu T; Wang X; Yang X; Zhou J; Hou Q; Yu L; Gao Y
BMC Complement Altern Med; 2016 Sep; 16(1):356. PubMed ID: 27618916
[TBL] [Abstract][Full Text] [Related]
4. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
Diener HC; Föh M; Iaccarino C; Wessely P; Isler H; Strenge H; Fischer M; Wedekind W; Taneri Z
Cephalalgia; 1996 Oct; 16(6):441-7. PubMed ID: 8902255
[TBL] [Abstract][Full Text] [Related]
5. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial.
Bordini CA; Arruda MA; Ciciarelli MC; Speciali JG
Arq Neuropsiquiatr; 1997 Sep; 55(3B):536-41. PubMed ID: 9629401
[TBL] [Abstract][Full Text] [Related]
6. Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients.
Lücking CH; Oestreich W; Schmidt R; Soyka D
Cephalalgia; 1988; 8 Suppl 8():21-6. PubMed ID: 3180198
[TBL] [Abstract][Full Text] [Related]
7. A comparative trial of flunarizine and propranolol in the prevention of migraine.
Shimell CJ; Fritz VU; Levien SL
S Afr Med J; 1990 Jan; 77(2):75-7. PubMed ID: 2404346
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of juvenile migraine using flunarizine or propranolol].
Lütschg J; Vassella F
Schweiz Med Wochenschr; 1990 Nov; 120(46):1731-6. PubMed ID: 2251492
[TBL] [Abstract][Full Text] [Related]
9. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability.
Sørensen PS; Larsen BH; Rasmussen MJ; Kinge E; Iversen H; Alslev T; Nøhr P; Pedersen KK; Schrøder P; Lademann A
Headache; 1991 Nov; 31(10):650-7. PubMed ID: 1769820
[TBL] [Abstract][Full Text] [Related]
10. Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine.
Bussone G; Cerbo R; Martucci N; Micieli G; Zanferrari C; Grazzi L; Fabbrini G; Cavallini A; Granella F; Ambrosoli L; Mailland F; Poli A; Manzoni G
Headache; 1999 Jun; 39(6):426-31. PubMed ID: 11279920
[TBL] [Abstract][Full Text] [Related]
11. Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study.
Soyka D; Taneri Z; Oestreich W; Schmidt R
Cephalalgia; 1988; 8 Suppl 8():35-40. PubMed ID: 3180201
[TBL] [Abstract][Full Text] [Related]
12. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
[TBL] [Abstract][Full Text] [Related]
13. Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial.
Lai KL; Niddam DM; Fuh JL; Chen SP; Wang YF; Chen WT; Wu JC; Wang SJ
Acta Neurol Scand; 2017 Apr; 135(4):476-483. PubMed ID: 27306581
[TBL] [Abstract][Full Text] [Related]
14. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
Mitsikostas DD; Polychronidis I
Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
18. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
Verspeelt J; De Locht P; Amery WK
Cephalalgia; 1996 Aug; 16(5):328-36; discussion 288. PubMed ID: 8869768
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
20. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
